← Eichor
Study identifier: NCT07630935 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Breast Cancer Risk Assessment in Night Shift Workers - Implementation of a Personalized Consultation

Condition: Breast Neoplasms Diagnosis  ·  Sponsor: Assistance Publique - Hôpitaux de Paris

PhaseN/A
Planned participants100
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersYes

About this study

This study evaluates adherence to a personalized prevention plan in female night shift workers at increased risk of breast cancer. Night shift work is associated with circadian disruption and increased cancer risk, as well as cardiovascular and reproductive health risks. Participants attend an initial consultation including clinical assessment and development of a personalized prevention plan targeting modifiable risk factors such as alcohol consumption, physical activity, smoking, diet, and weight. Follow-up is conducted remotely over 5 years to assess adherence to recommendations and screening. Participant satisfaction and adherence to additional consultations are also evaluated.

This description comes directly from the study's public registry record.

Talk to the study team

Amelia FAVIER, MD  ·  +331.42.17.81.14  ·  amelia.favier@aphp.fr

Always discuss trial participation with your own doctor first.

Locations (1)

Pitié Salpêtrière hospitalParis, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07630935